Label-free optical sensing platform that detects microbial contamination in aqueous solutions by measuring resonant shifts in Whispering Gallery Mode resonators. Enables real-time identification, counting, and viability assessment of bacteria for water quality, pharmaceutical, and clinical applications.
This solution offers a label-free optical detection platform for microbial contamination in aqueous solutions, based on Whispering Gallery Mode (WGM) resonator technology. WGM resonators are microscale optical structures that trap light along their curved surfaces; when microbial cells bind to the sensing surface, the effective refractive index changes, producing measurable shifts in the resonance signal. These shifts reveal the presence, concentration, and potentially the viability of contaminating microorganisms without the need for fluorescent or chemical labels.
The platform addresses critical needs in pharmaceutical manufacturing, clinical diagnostics, dialysis safety, and environmental water monitoring, where rapid and reliable detection of microbial contamination is essential. Two product versions are envisioned: a professional unit for manufacturing sites and hospitals, and a portable unit for patient home use.
The technology is currently at an early-to-mid stage of development. Proof-of-concept has been established through nanoparticle detection and through experimental detection of Bovine serum albumin molecules in phosphate-buffered saline, where binding events produced measurable redshifts in WGM resonances. Future validation efforts include developing a WGM sensor specifically tailored for bacterial cell detection, benchmarking performance in saline and dialysis solutions, and building two prototype versions for professional and portable use cases. The research team is actively advancing toward prototype development and eventual commercialization.
Washington University in St. Louis is a private research university with a large graduate and professional footprint and a major clinical enterprise. Its medical campus is integrated with a leading hospital system, enabling joint clinical research, secure data access, and large-scale trial recruitment. An adjacent innovation district and partner incubators provide flexible lab space, prototyping resources, and corporate co-location, while shared core facilities welcome external users under service agreements. Research is supported by NIH, NSF, DOE, and other competitive federal funding alongside industry sponsorship. A dedicated technology transfer office manages IP, licensing, startup formation, and streamlined sponsored research and clinical trial agreements.